Evidence map›Paper›PMID 36437464›Full record

Observational studyBMC gastroenterology2022

Potential association of eEF1A dimethylation at lysine 55 in the basal area of Helicobacter pylori-eradicated gastric mucosa with the risk of gastric cancer: a retrospective observational study.

Yuka Hirashita, Masahide Fukuda, Masaaki Kodama, Yoshiyuki Tsukamoto, Tadayoshi Okimoto, Kazuhiro Mizukami, Yoshinari Kawahara, Yasuhiro Wada, Sotaro Ozaka, Kazumi Togo and 8 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Yuka HirashitaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan. not-minamino@oita-u.ac.jp.
Masahide FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Masaaki KodamaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Yoshiyuki TsukamotoDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
Tadayoshi OkimotoDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Kazuhiro MizukamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Yoshinari KawaharaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Yasuhiro WadaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Sotaro OzakaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Kazumi TogoDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Keisuke KinoshitaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Takafumi FuchinoDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Kensuke FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Kazuhisa OkamotoDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Ryo OgawaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Osamu MatsunariDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Koichi HondaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Oita, 879-5593, Japan.
Oita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough eradication therapy for chronic Helicobacter pylori (H. pylori) reduces the risk of gastric cancer (GC), its effectiveness is not complete. Therefore, it is also critically important to identifying those patients who remain at high risk after H. pylori eradication therapy. Accumulation of protein methylation is strongly implicated in cancer, and recent study showed that dimethylation of eEF1A lysine 55 (eEF1AK55me2) promotes carcinogenesis in vivo. We aimed to investigate the relationship between eEF1A dimethylation and H. pylori status, efficacy of eradication therapy, and GC risk in H. pylori-eradicated mucosa, and to reveal the potential downstream molecules of eEF1A dimethylation.

methodsRecords of 115 patients (11 H. pylori-negative, 29 H. pylori-positive, 75 post-eradication patients) who underwent upper gastrointestinal endoscopy were retrospectively reviewed. The eEF1A dimethyl level was evaluated in each functional cell type of gastric mucosa by immunofluorescent staining. We also investigated the relationship between eEF1AK55me2 downregulation by CRISPR/Cas9 mediated deletion of Mettl13, which is known as a dimethyltransferase of eEF1AK55me2.

resultsThe level of eEF1A dimethylation significantly increased in the surface and basal areas of H. pylori-positive mucosa compared with the negative mucosa (surface, p = 0.0031; basal, p = 0.0036, respectively). The eEF1A dimethyl-levels in the surface area were significantly reduced by eradication therapy (p = 0.005), but those in the basal area were maintained even after eradication therapy. Multivariate analysis revealed that high dimethylation of eEF1A in the basal area of the mucosa was the independent factor related to GC incidence (odds ratio = 3.6611, 95% confidence interval = 1.0350-12.949, p = 0.0441). We also showed the relationship between eEF1A dimethylation and expressions of reprogramming factors, Oct4 and Nanog, by immunohistochemistry and in vitro genome editing experiments.

conclusionsThe results indicated that H. pylori infection induced eEF1A dimethylation in gastric mucosa. The accumulation of dimethyl-eEF1A in the basal area of the mucosa might contribute to GC risk via regulation of reprograming factors in H. pylori eradicated-gastric mucosa.

Indexed as

Helicobacter pyloriStomach NeoplasmsGastric MucosaHumansLysineRetrospective StudiesLysineAtrophic gastritisGastric cancerMethylationRisk factor

Identifiers

PMID36437464
PMCPMC9703661
OpenAlexW4310028661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.